mRNA optimization for targeted cell or tissue requires large scale screening in vitro and in vivo. The high R&D cost hinders the most potential applications in disease treatment. RNAuto Platform is an one-step, automatic mRNA platform from RNACure, taking advantage of core materials produced by ourselves in screening and optimization.
Start with target proteins in target diseases
- Design and optimize the sequence, the frame, and modification of mRNA
- Varied modified nucleotides for efficiency screening
- Screen and deliver mRNA into cultured cells, experimental animals for preclinical studies
- Build up clinical trials for promising mRNA drugs